Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 29

Trial Status

Completed5
Terminated3
Other2

Role Distribution

Principal Investigator1
Other Roles9
PI Rate10%

Activity Timeline

Clinical Trials (10)

NCT00005029Phase 2Terminated
Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
Ovarian CancerPrimary Peritoneal Cavity Cancer
Studychair

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Cancer of the Uterine CervixEndometrial CarcinomaOvary Cancer+1 more
Similarity Score20%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Cancer of the Uterine CervixOvary CancerSarcoma
Similarity Score15%

Lei Li, M.D.

Peking Union Medical College Hospital

Related
46 trials

Shared therapeutic areas:

Cancer of the Uterine CervixEndometrial CarcinomaOvary Cancer
Similarity Score15%

Francesco Perrone, M.D., Ph.D.

National Cancer Institute, Naples

Related
13 trials

Shared therapeutic areas:

Ovary CancerCancer of the Uterine CervixEndometrial Carcinoma
Similarity Score15%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Cancer of the Uterine CervixOvary CancerSarcoma
Similarity Score15%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Ovary CancerCancer of the Uterine Cervix

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Xiaoli Lan, PhD

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Related
16 trials

Shared therapeutic areas:

SarcomaOvary Cancer
Similarity Score10%

Steven A. Rosenberg, MD, PhD

NCI - Surgery Branch

Related
29 trials

Shared therapeutic areas:

Ovary CancerSarcoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

James L Gulley, M.D.

National Cancer Institute (NCI)

Related
18 trials

Shared therapeutic areas:

Ovary CancerSarcoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (10)

Showing 10 of 10 trials

NCT00003156Phase 2StudyChair

Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus

Sarcoma
Terminated
NCT00003523Phase 2StudyChair

Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum

Ovarian CancerPrimary Peritoneal Cavity Cancer
Completed
NCT00003821Phase 2StudyChair

Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer

Endometrial Cancer
Withdrawn
NCT00005029Phase 2StudyChair

Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer

Ovarian CancerPrimary Peritoneal Cavity Cancer
Terminated
NCT00087087Phase 2StudyChair

Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Ovarian CancerPrimary Peritoneal Cavity Cancer
Completed
NCT00087100Phase 2StudyChair

Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer

Endometrial Cancer
Completed
NCT00087113Phase 2StudyChair

Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix

Cervical Cancer
Completed
NCT00096187Phase 2StudyChair

Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy

Gestational Trophoblastic Tumor
Terminated
NCT00691301Phase 2StudyChair

Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Cervical Cancer
Completed
NCT01119573PrincipalInvestigator

Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer

Endometrial Cancer
Unknown

All 10 trials loaded